Medical School of Chinese PLA, Beijing, 100853, China.
Department of Orthopedics, The First Medical Center, Chinese People's Liberation Army General Hospital, Fuxing Road, Haidian District, Beijing, 100048, China.
J Orthop Surg Res. 2022 Jun 27;17(1):330. doi: 10.1186/s13018-022-03218-x.
Managing periprosthetic joint infections are variable in practices. Debridement, antibiotics, and implant retention (DAIR) is one of the favorable interventions. Given that the success rate of the two-stage revision total knee arthroplasty (rTKA) might be overestimated. The purpose of this study is to compare the success rate between DAIR and standard two-stage rTKA with a comparable intervention time.
We retrospectively reviewed the consecutive knee periprosthetic joint infection cases which underwent DAIR or two-stage rTKA (all procedures were performed by the senior author) within 12 weeks since their primary TKA between July 2009 and October 2019. Average follow-up was 72.20 ± 40.70 months (range 29-148 months) in the DAIR group compared to 89.14 ± 43.06 months after spacer insertion (range 29-163 months) in the two-stage revision group (P = 0.156). According to different interventions, demographic data; timing of surgical intervention; hospital for special surgery knee score; and success rate were collected and compared between the DAIR group and two-stage revision group. Failure of treatment was based on the Delphi consensus and the fate of spacers. The pathogen types and failure cases were also recorded and analyzed.
Average follow-up was 72.20 ± 40.70 months (range 29-148 months) in the DAIR group compared to 89.14 ± 43.06 months after spacer insertion (range 29-163 months) in the two-stage revision group. Time from index surgery was 3.90 ± 2.92 weeks (range 0-12 weeks) in the DAIR group, and 5.11 ± 2.86 weeks (range 0-12 weeks) in the 2-stage exchange group, respectively. The success rate was 70.0% and 75.0% in the DAIR group and two-stage revision group, respectively. But no significant differences were observed between the two groups.
DAIR demonstrated comparable effectiveness with two-stage rTKA. We recommended DAIR as a choice for patients with current infection within 12 weeks after primary TKA. For methicillin-resistant staphylococcal infections and fungal infections, two-stage rTKA might be preferred.
在实践中,处理假体周围关节感染的方法各不相同。保留清创、抗生素和植入物(DAIR)是一种有利的干预措施。鉴于二期翻修全膝关节置换术(rTKA)的成功率可能被高估,本研究旨在比较 DAIR 与标准二期 rTKA 在可比干预时间内的成功率。
我们回顾性分析了 2009 年 7 月至 2019 年 10 月期间,在初次 TKA 后 12 周内接受 DAIR 或二期 rTKA(所有手术均由资深作者完成)的连续膝关节假体周围关节感染病例。DAIR 组的平均随访时间为 72.20±40.70 个月(范围 29-148 个月),而二期翻修组在放置间隔器后为 89.14±43.06 个月(范围 29-163 个月)(P=0.156)。根据不同的干预措施,收集并比较了 DAIR 组和二期翻修组的人口统计学数据、手术干预时机、美国特种外科医院膝关节评分和成功率。治疗失败的依据是 Delphi 共识和间隔器的命运。还记录并分析了病原体类型和失败病例。
DAIR 组的平均随访时间为 72.20±40.70 个月(范围 29-148 个月),而二期翻修组在放置间隔器后为 89.14±43.06 个月(范围 29-163 个月)。DAIR 组的手术时间为 3.90±2.92 周(范围 0-12 周),二期翻修组为 5.11±2.86 周(范围 0-12 周)。DAIR 组和二期翻修组的成功率分别为 70.0%和 75.0%,但两组间无显著差异。
DAIR 与二期 rTKA 具有相当的疗效。我们建议将 DAIR 作为初次 TKA 后 12 周内发生当前感染患者的选择。对于耐甲氧西林金黄色葡萄球菌感染和真菌感染,可能更倾向于采用二期 rTKA。